JESIKA SWEET: Open Payments
NPI 1245808484 · WICHITA FALLS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$732 in 29 payments from 11 companies in 2025. Trend: 2023 $62 · 2024 $89 · 2025 $732
Food & beverage: $732
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 14 | $256 |
| E.R. Squibb & Sons, L.L.C. | 2 | $104 |
| Collegium Pharmaceutical, Inc. | 3 | $103 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $100 |
| Alkermes, Inc. | 2 | $38 |
| ABBVIE INC. | 2 | $35 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Neurocrine BioSciences, Inc. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
Products named: REXULTI, COBENFY, Jornay PM, CAPLYTA, ARISTADA, VRAYLAR, ABILIFY MAINTENA, FANAPT.
Industry payments across TX — which companies pay providers there.
